Global Innovative Platforms

GIPL · OTC

$0.50+$0.0311 (+6.63%)TodayMarket closed ·
No price history for this range.

About GIPL

Global Innovative Platforms, Inc. is a development-stage company focused on advancing diagnostic technologies in the animal health sector. The company is headquartered in Maitland, Florida. The company went IPO on 2003-12-23. The firm develops non-invasive diagnostic tools for detecting diseases, assessing treatment effectiveness, and monitoring potentially toxic environmental and food conditions. Its proprietary technologies, VOCAM Plus and the FROG, utilize advanced gas chromatography and artificial intelligence (AI) software to provide rapid breath and air analysis. VOCAM technology consists of two components: one which it is developing to collect the samples, and a second component to process and analyze breath samples that indicate multiple volatile organic compounds (VOC) on a single reading to measure a variety of potential threats, including its initial focus on the heartworm market. FROG utilizes similar technology as the VOCAM Plus, but it also includes a collection wand, to collect samples, eliminating the need for an external water, soil, feed, or air collection device.

Employees
0
Headquarters
Maitland, Florida
Listed
Dec 23, 2003
Sector
Health Care
Industry
Health Care Equipment & Supplies

Leadership

Global Innovative Platforms executives
NameTitleSince
Kevin Worth—2014
Andrew Brown—2023
Richard Hahn——
Ronald Hickling—2004
Harry Halamandaris——
George Lange——
Amb. E. Michael Ussery——

Similar companies

Companies in the same industry as Global Innovative Platforms

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.